PubRank

R Brookmeyer

Author PubWeight™ 134.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997 18.10
2 Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997 15.49
3 Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001 13.32
4 Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000 3.89
5 Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987 3.58
6 A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998 3.54
7 Statistical models for prevalent cohort data. Biometrics 1993 3.16
8 Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med 1988 3.08
9 Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS 1987 3.01
10 Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000 2.37
11 Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol 1997 2.36
12 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997 2.30
13 Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 1987 2.29
14 Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet 1986 2.28
15 Effects of mid-point imputation on the analysis of doubly censored data. Stat Med 1992 2.09
16 Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology 2003 2.06
17 Prevalence of dementia after age 90: results from the 90+ study. Neurology 2008 1.88
18 Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983 1.75
19 Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996 1.74
20 Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol 1995 1.72
21 US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis 2000 1.65
22 Modelling paired survival data with covariates. Biometrics 1989 1.59
23 Factors influencing the age at natural menopause. J Chronic Dis 1987 1.57
24 Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol 1989 1.54
25 Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986 1.46
26 Variation in the duration of protection given by screening using the Pap test for cervical cancer. J Clin Epidemiol 1989 1.44
27 Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol 1991 1.41
28 The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epidemiol 1987 1.32
29 Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis 1996 1.30
30 Predictors of stroke risk in coronary artery bypass patients. Ann Thorac Surg 1997 1.30
31 Estimating a treatment effect from multidimensional longitudinal data. Biometrics 1998 1.25
32 Matched case-control designs and overmatched analyses. Am J Epidemiol 1986 1.16
33 Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. Am J Epidemiol 1998 1.14
34 Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol 1995 1.09
35 Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cogn 1996 1.09
36 Use of cancer controls in case-control cancer studies. Am J Epidemiol 1987 1.06
37 Aging and the public health effects of dementia. N Engl J Med 2001 1.05
38 Global effects estimation for multidimensional outcomes. Stat Med 2007 1.02
39 Familial cancer history and chronic lymphocytic leukemia. A case-control study. Am J Epidemiol 1989 1.01
40 Methods for projecting course of acquired immunodeficiency syndrome epidemic. J Natl Cancer Inst 1988 0.99
41 U.S. nephrologists' attitudes towards renal transplantation: results from a national survey. Transplantation 2001 0.97
42 APOE genotype and survival in men and women with Alzheimer's disease. Neurology 2002 0.97
43 Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging 2005 0.97
44 Factors influencing waiting time and successful receipt of cadaveric liver transplant in the United States. 1990 to 1992. Med Care 1998 0.96
45 Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994. MMWR Recomm Rep 1992 0.96
46 Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 1991 0.95
47 Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol 1987 0.93
48 Analysis of infectious disease data from partner studies with unknown source of infection. Biometrics 1993 0.92
49 Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987 0.91
50 Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am J Epidemiol 1987 0.91
51 Bivariate frailty model for the analysis of multivariate survival time. Lifetime Data Anal 1996 0.90
52 Managed mental health care and patterns of inpatient utilization for treatment of affective disorders. Soc Psychiatry Psychiatr Epidemiol 1995 0.90
53 Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 1985 0.88
54 Covariate-dependent genetic counseling in Huntington's disease. J Neurogenet 1986 0.87
55 Chronic lymphocytic leukemia and acquired disorders affecting the immune system: a case-control study. J Natl Cancer Inst 1986 0.85
56 Case-control studies for estimation of the natural history of preclinical disease from screening data. Stat Med 1986 0.85
57 The diversity of T cell receptors specific for self MHC gene products. J Immunol 1983 0.82
58 Measuring HIV-1 incidence in northern Thailand: prospective cohort results and estimates based on early diagnostic tests. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.81
59 Modeling Maternal-Infant HIV Transmission in the Presence of Breastfeeding with an Imperfect Test. Biometrics 2007 0.80
60 Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: the epidemic in India. AIDS 1996 0.79
61 The evolution of virus diseases: their emergence, epidemicity, and control. Virus Res 1993 0.79
62 AIDS surveillance and prediction of the HIV and AIDS epidemic: methodological developments. AIDS 1993 0.79
63 Suicide and HIV infection. Mortality follow-up of 4147 HIV-seropositive military service applicants. JAMA 1996 0.78
64 Energy requirements of parenterally fed bone marrow transplant recipients. JPEN J Parenter Enteral Nutr 1985 0.78
65 Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection. Sex Transm Dis 1997 0.77
66 More on the relation between AIDS cases and HIV prevalence. N Engl J Med 1989 0.77
67 Prediction intervals for survival data. Stat Med 1984 0.76
68 Simulation of Huntington's disease onset. Genet Epidemiol 1989 0.75
69 An application of Bayesian analysis to medical follow-up data. Stat Med 1986 0.75
70 The effect of additional follow-up and accrual on survival time data. Biometrics 1985 0.75
71 An empirical Bayes approach to smoothing in backcalculation of HIV infection rates. Biometrics 1995 0.75
72 Application of random effects models and other methods to the analysis of multidimensional quality of life data in an AIDS clinical trial. Med Care 1999 0.75
73 Regression analysis of discrete time survival data under heterogeneity. Stat Med 1997 0.75
74 Methods for projecting the AIDS epidemic. Lancet 1987 0.75
75 Assessing the impact of additional follow-up in cohort studies. Am J Epidemiol 1985 0.75